Please enable Javascript
Novartis
Advertisement
FDA Declines Canakinumab to Prevent CVD
Kaitlyn D’Onofrio
Cardiology
|
October 22, 2018
The U.S. Food and Drug Administration (FDA) has rejected canakinumab to be used to reduce the risk of cardiovascular ...
Read More
Advertisement
Advertisement